Trial reportSupportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer2025
Examining the effectiveness of combination therapy in alleviating peripheral neuropathy and sleep disorders in breast cancer patients receiving chemotherapy.
Trial report in Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectiveExploring the efficacy of compression therapy and combined therapies in alleviating chemotherapy-induced peripheral neuropathy and sleep disturbances in breast cancer patients.
methodsA total of 120 breast cancer patients who developed chemotherapy-induced peripheral neuropathy (CIPN) after receiving chemotherapy at Tangshan People's Hospital were consecutively enrolled and randomly assigned into three groups. The control group received standard treatment, while the compression group received a three-level pressure compression therapy in addition to standard treatment. The combination group received a combined therapy (compression combined with exercise). Assessments were conducted using the National Cancer Institute-Common Toxicity Criteria (NCI-CTC version 4.0) and the Pittsburgh Sleep Quality Index (PSQI) before intervention, after four cycles of intervention, and at a 6-month follow-up. Comparisons were made among the three groups in terms of the incidence of CIPN and differences in PSQI scores.
resultsWe proposed a novel "dual-target intervention" strategy: reducing chemotherapy drug retention (mechanical protection) through hand and foot compression (with a pressure of 30-48 mmHg) and promoting nerve repair (functional repair) through progressive EXCAP exercise (with a weekly step count increase of 5-20%). In the combination group, the proportion of patients with grade 1 CIPN was significantly higher than that in the compression group and the control group after four cycles of intervention (100.0 vs. 75.0 vs. 50.0%, P < 0.001), while the proportion of patients with grade 2 CIPN was significantly lower than that in the compression group and the control group (0.0 vs. 25.0 vs. 50.0%, P < 0.001). Moreover, this effect persisted until the 6-month follow-up (grade 0 72.2 vs. 44.4 vs. 19.4%, P < 0.001; grade 1 27.8 vs. 38.9 vs. 41.7%, P < 0.001; grade 2 0.0 vs. 16.7 vs. 38.9%, P < 0.001). The reduction in total PSQI score was significantly greater in the combination group versus the control at the 4-cycle assessment (P < 0.001). A generalized estimating equation (GEE) confirmed significant effects of time, group, and their interaction (all P < 0.001). At the four-cycle intervention point and the 6-month follow-up, the total HADS scores in the combination group and the compression group were significantly lower than those in the control group, and the total HADS score in the combination group was lower than that in the compression group (P < 0.001).
conclusionBoth intervention methods can effectively reduce the incidence of CIPN in breast cancer patients undergoing chemotherapy, improve their sleep quality, and alleviate negative emotions. Moreover, the combination group outperforms the compression group, and this mechanism may be related to multi-pathway regulation involving metabolism, nerve function, and psychological factors.
Indexed as
Identifiers
41074991What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.